申请人:Merck & Co., Inc.
公开号:US06399640B1
公开(公告)日:2002-06-04
Substituted 5-aryl-2,4-thiazolidinediones or 5-aryl-2,4-oxazolidinediones that also carry a second substituent in the 5-position of the heterocyclic ring are potent agonists of PPAR, and are therefore useful in the treatment, control or prevention of diabetes, hyperglycemia, hyperlipidemia (including hypercholesterolemia and hypertriglyceridemia), atherosclerosis, obesity, vascular restenosis, and other PPAR &agr;, &dgr; and/or &ggr; mediated diseases, disorders and conditions.
5-芳基-2,4-噻唑烷二酮或5-芳基-2,4-噁唑烷二酮,在杂环环的5-位置还带有第二取代基,是PPAR的有效激动剂,因此在糖尿病、高血糖、高脂血症(包括高胆固醇血症和高甘油三酯血症)、动脉粥样硬化、肥胖、血管再狭窄和其他PPAR α、δ和/或γ介导的疾病、紊乱和病况的治疗、控制或预防中是有用的。